TX45 was well-tolerated with no observed immunogenicity, and demonstrated a favorable PK/PD relationship which was used to identify doses for the ...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced new positive efficacy, safety and ...

在当地时间9月15日的中枢神经系统肿瘤简短口头报告专场，首都医科大学附属北京天坛医院李文斌教授就“A Phase I study for safety, tolerability, pharmacokinetics, and anti-tumor ...

The long-term safety of TEV-‘749 and incidence of PDSS are also being evaluated in the SOLARIS open-label study (Period 2), with safety data topline readout expected in the first half of 2025.

Severe obesity is already a significant problem for many children, especially since obese children often become obese adults. Could the now popular weight-loss injection drugs be a solution for those ...

英矽智能创始人兼首席执行官Alex Zhavoronkov博士表示：“ ...

Novo Nordisk A/S's shares have stalled recently, but this looks like a natural digestion of gains from prior years. Click for ...

Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and ...

The release of early-stage data on three oral weight loss drug candidates hints at which companies have the strongest hand, ...

Only one is FDA-approved for hair loss. Topical minoxidil is FDA-approved specifically for the treatment of pattern baldness.

Recursion Pharmaceuticals has an exciting approach to developing therapies. The company recently reported positive phase 2 ...

Shares of biopharma outfit Edgewise Therapeutics ( EWTX 47.93%) soared more than 50% today, reaching a three-year high ...